WO2011008222A1 - System for using electrical muscle stimulation to increase blood flow in body parts - Google Patents
System for using electrical muscle stimulation to increase blood flow in body parts Download PDFInfo
- Publication number
- WO2011008222A1 WO2011008222A1 PCT/US2009/057838 US2009057838W WO2011008222A1 WO 2011008222 A1 WO2011008222 A1 WO 2011008222A1 US 2009057838 W US2009057838 W US 2009057838W WO 2011008222 A1 WO2011008222 A1 WO 2011008222A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrode
- operative
- body part
- electrodes
- electrical
- Prior art date
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 56
- 210000003205 muscle Anatomy 0.000 title claims abstract description 43
- 230000017531 blood circulation Effects 0.000 title claims abstract description 22
- 230000004118 muscle contraction Effects 0.000 claims abstract description 18
- 230000001965 increasing effect Effects 0.000 claims abstract description 12
- 238000004891 communication Methods 0.000 claims abstract description 11
- 230000004936 stimulating effect Effects 0.000 claims abstract description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- YYPNJNDODFVZLE-UHFFFAOYSA-N 3-methylbut-2-enoic acid Chemical compound CC(C)=CC(O)=O YYPNJNDODFVZLE-UHFFFAOYSA-N 0.000 claims description 3
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 230000008468 bone growth Effects 0.000 claims description 3
- 125000004386 diacrylate group Chemical group 0.000 claims description 3
- 239000000017 hydrogel Substances 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 239000004626 polylactic acid Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 230000029663 wound healing Effects 0.000 claims description 3
- 210000003414 extremity Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 206010051055 Deep vein thrombosis Diseases 0.000 description 8
- 206010047249 Venous thrombosis Diseases 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000002232 neuromuscular Effects 0.000 description 7
- 210000002414 leg Anatomy 0.000 description 6
- 239000000556 agonist Substances 0.000 description 5
- 239000005557 antagonist Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000011882 arthroplasty Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000020764 fibrinolysis Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000010006 flight Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 231100000878 neurological injury Toxicity 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000009295 sperm incapacitation Effects 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/10—Leg
- A61H2205/106—Leg for the lower legs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0464—Specially adapted for promoting tissue growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
Definitions
- the described invention relates in general to a system for increasing blood flow in certain body areas of a patient, and more specifically to an apparatus and method for increasing blood flow in the trunk and extremities for medical and non-medical purposes using electrical muscle stimulation, also referred to herein as neuromuscular stimulation.
- the causative factors surrounding the precipitation of DVT are known and include vessel wall and valvular damage and blood stasis resulting from immobilization during or following surgery. Removal of endogenous fibrinolysis which is produced by contracting muscles may also be a causative factor.
- Muscle contractions are an integral component of the physiology of circulation.
- SCDs sequential compression devices
- SCDs are typically used as an adjunct therapy to facilitate blood flow to the lower extremities.
- electrical stimulation is superior to SCDs. While cardiac output dropped 20% below baseline, the electrical stimulation group increased 20% (Faghri, IEEE 591 : 62-69; March 1997).
- NMES Neuromuscular stimulation
- This involuntary effect is particularly advantageous for (i) surgical patients who are anesthetized or under a local epidural block; (ii) patients who are bedridden due to disability, age, or disease; or (iii) are paralyzed from spinal cord injury, stroke, or other neurological injuries or diseases. This effect would also be useful for people who are prevented from moving for long periods of time, such as those on long-duration flights or during extended period of sleep.
- a system for electrically stimulating muscles and increasing blood flow in one or more body parts includes at least one electrode adapted to be placed circumferentially (i.e., completely) around a body part such as an arm or leg wherein the at least one electrode is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part; at least one stimulation module in electrical communication with the at least one electrode, wherein the at least one stimulation module is operative to provide electrical impulses to the at least one electrode; and at least one control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
- a system for electrically stimulating muscles and increasing blood flow to a body part includes at least two electrodes adapted to be placed circumferentially around a body part, wherein each of the at least two electrodes is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part; at least one stimulation module in electrical communication with each of the at least two electrodes, wherein the at least one stimulation module is operative to provide electrical impulses to each of the at least two electrodes; and at least one control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
- a device for electrically stimulating muscles or muscle groups includes at least one electrode adapted to be placed circumferentially (i.e., completely) around a body part such as an arm, leg, or trunk, wherein the at least one electrode is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part.
- FIG. 1 depicts an exemplary embodiment of the electrical muscle stimulation system of the present invention wherein multiple electrical stimulation assemblies have been placed on multiple body parts of an individual;
- FIG. 2 illustrates the placement of an exemplary embodiment of the electrical stimulation system of the present invention wherein a single electrical stimulation assembly has been placed on the lower portion of one leg of an individual;
- FIG. 3 is a cross-sectional view of a limb segment depicting the flow of an electrical current into both agonist and antagonist muscle groups from the circumferential electrode of the present invention
- FIG. 4 is a longitudinal view of a limb segment depicting the flow of an electrical current generated by the circumferential electrodes of the present invention.
- FIG. 5 is a graph depicting an exemplary order of stimulation for pushing blood proximally using the electrical muscle stimulation system of the present invention.
- the present invention relates to a neuromuscular stimulation system (NMES) for use in treating DVT and other medical and non-medical conditions by inducing singular and or co-contractions of muscle groups to increase blood and oxygen flow in those muscles.
- NMES neuromuscular stimulation system
- Other intended uses and benefits of the present invention include wound healing, muscle strengthening, and stimulation of bone growth.
- first and second general embodiments of this invention provide a system for electrically stimulating muscles and increasing blood flow in one or more body parts such as the trunk or extremities; and a third general embodiment of this invention provides a device in the form of a circumferential electrode for electrically stimulating muscles or muscle groups, wherein the electrode is capable of completely encircling a human body part for increasing blood circulation.
- the electrode is supplied with electrical impulses to induce muscle contractions and may be shifted proximally or distally on the body part without degradation of muscle contraction while providing for concurrent agonist and antagonist muscle regeneration.
- FIG. 1 depicts an exemplary embodiment of neuromuscular stimulation system
- Each assembly 20 typically includes a first circumferential electrode 22 and a second circumferential electrode 24, both of which are in electrical communication with a stimulation module 26, which is connected to each circumferential electrode by at least one wire 28 (see FIG. 2).
- Stimulation module 26 typically communicates with control module 40 by wireless means, as depicted by reference number 27.
- Each assembly 20 typically includes a fabric sleeve 30, which acts as a substrate or support for the components thereof.
- One or more sleeves 30 may be included in a larger garment- like item 32, which may connect sleeves 30 to one another for the purpose a facilitating proper placement of system 10 on a user thereof.
- FIG. 2 illustrates the placement of an assembly 20 on the lower portion of one leg of an individual.
- FIG. 3 provides a cross-sectional view of a limb segment depicting the flow of an electrical current into both agonist muscle 50 and antagonist muscle 52 from circumferential electrode 22.
- An electrical field 56 is generated by electrode 22 and passes through skin 54 into the muscles of the limb upon which electrode 22 has been placed.
- FIG. 4 is a longitudinal view of a limb segment depicting the flow of an electrical current generated by the circumferential electrodes of the present invention.
- electrodes 22 and 24 have been placed in sequence (i.e., tandem) on the leg of a patient for the purpose of creating electrical field 56.
- FIG. 5 provides a graph that depicts an exemplary method of electrical stimulation for pushing blood proximally using an exemplary embodiment of neuromuscular stimulation system 10.
- each muscle group (agonist and antagonist) being treated is typically controlled by one set of circumferential electrodes 22, 24 and one integrated stimulation module 26, which coordinates the electrical impulses between the electrodes, which may be controlled remotely from the electrodes.
- stimulation module 26 is equipped with electronics and battery power used deliver adequate stimulation.
- Each stimulation module 26 receives a wireless signal 27 from control module 40 for properly coordinating the contraction of muscle groups.
- Stimulation module 26 may also include electronic means for monitoring contractions of a body part and providing selected electrical impulses to the circumferential electrodes.
- stimulation module 26 has a width of approximately two inches or less and may be extensible in length.
- control module 40 is also capable of monitoring the status of equipment, electrode impedance, compliance and blood flow and then delivering this information to clinicians. Control module 40 may be used to adjust the level of electrical stimulation in accordance with the need for increased or decreased blood flow in or out of the treated limb in a closed-loop feedback manner.
- the circumferential electrodes of the present invention are typically 1-2 inches in width and the area of coverage is significantly higher than the conventional electrodes typically used in NMES.
- the current density (CD) of the circumferential electrodes is significantly lower, even at high intensity outputs, meaning they are more comfortable than conventional electrodes.
- a conventional electrode would have an area of 2 x 4 inches equaling 8 square inches; whereas a circumferential electrode (around a typical thigh) would have an area 1 x 25 inches equaling 25 square inches.
- the electrical impulse parameters for each circumferential electrode include an amplitude of about 0.1-150 mA; a pulse width of about 0.1- 400 microseconds; a frequency of 25-50 Hz; and a duty cycle of about 5-10 seconds ON, and about 10-60 seconds OFF.
- circumferential electrodes 22, 24 utilize either an adhesive or non-adhesive biogel to interface with the patient's skin.
- This biogel may include hydrogel polymers, polymerized polyethylene glycol diacrylate, polylactic acid, polyglycolic acid, polymerized polyethylene glycol dimethylacrylate and mixtures thereof.
- the circumferential electrodes of the present invention are extensible in length (including the biogel) to accommodate expansion in girth as muscle contracts so as to not constrict the limbs and to maintain electrode-to-skin contact; and are flexible for accommodating the contours of limbs which may vary widely due to variations in underlying muscle and bone.
- Neuromuscular stimulation system 10 and the various components thereof may be provided as a portable kit that includes instructions for proper placement of the electrodes and proper use of the system.
- a primary advantage of the present invention is that circumferential electrodes 22,
- the circumferential electrodes 24 transmit electrical current through the patient's skin and body in a highly efficient manner.
- the electrical current generated by these circumferential electrodes travels in a perpendicular fashion with respect to the planar surface of the electrode and then along a parallel pathway, in the long direction of the limb segment (see FIGS 3-4).
- These aspects of the disclosed circumferential electrodes results in much less discomfort to the patient.
- the reduced level of discomfort is also due to lower current densities emitted by the circumferential electrodes as compared to more traditional electrodes.
- the circumferential electrodes of the present invention do not have to be placed accurately to effectively excite muscle tissue. These electrodes may be shifted proximally or distally, while still inducing muscle contractions without compromising the quality of stimulation or level of comfort.
- the disclosed circumferential electrodes reduce the number of required electrodes and stimulation channels by one-half, making a NMES system utilizing these electrodes far easier to operate than known systems.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
A system for stimulating muscles and increasing blood flow in one or more specific body parts is provided. This system includes at least one electrode adapted to be placed circumferentially around a body part, wherein the at least one electrode is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part; at least one stimulation module in electrical communication with the at least one electrode, wherein the at least one stimulation module is operative to provide electrical impulses to the at least one electrode; and a control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
Description
TITLE OF INVENTION: SYSTEM FOR USING ELECTRICAL MUSCLE
STIMULATION TO INCREASE BLOOD FLOW IN BODY PARTS
INVENTOR(S): Philip Muccio Ypsilanti, Michigan
ASSIGNEE: N/A
ATTORNEY: (Mr.) Courtney J. Miller
Reg. No. 45,366
FIRM: McNees Wallace & Nurick LLC
21 East State Street, Suite 1700
Columbus, Ohio 43215
Telephone: 614-719-2858
Facsimile: 614-469-4653
CUSTOMER NUMBER: 26587
TITLE OF THE INVENTION
SYSTEM FOR USING ELECTRICAL MUSCLE STIMULATION TO INCREASE
BLOOD FLOW IN BODY PARTS
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This patent application claims the benefit of U.S. Provisional Patent Application
Serial No. 61/225,703 filed on July 15, 2009 and entitled "Electrical Stimulation System for Treatment of Deep Vein Thrombosis" and U.S. Non-Provisional Patent Application Serial No. 11/466,637 filed on August 23, 2006 and entitled "System and Device for Neuromuscular Stimulation," the disclosures of which are incorporated by reference herein in their entirety and made part of the present U.S. non-provisional patent application for all purposes.
BACKGROUND OF THE INVENTION
[0002] The described invention relates in general to a system for increasing blood flow in certain body areas of a patient, and more specifically to an apparatus and method for increasing blood flow in the trunk and extremities for medical and non-medical purposes using electrical muscle stimulation, also referred to herein as neuromuscular stimulation.
[0003] Diminished circulation in the extremities of a patient can lead to serious medical complications including death. Promoting circulatory health is essential for many patients who are susceptible to ongoing reduced blood or lymph flow stemming from pathology of the circulatory system, lymphatic system, or muscles (including paralysis from neurological insult); or in patients with short-term reduction in blood flow resulting from temporary incapacitation or immobilization, particularly from surgery involving the abdomen or joint replacement of the lower extremities. The incidence of deep vein thrombosis (DVT) in hip and knee arthroplasty typically ranges from forty to seventy percent. The incidence of pulmonary emboli (PE) in knee and hip arthroplasty patients is typically two to three percent. The causative factors surrounding the precipitation of DVT are known and include vessel wall and valvular damage and blood stasis resulting from immobilization during or following surgery. Removal of endogenous fibrinolysis which is produced by contracting muscles may also be a causative factor.
[0004] Muscle contractions are an integral component of the physiology of circulation.
Without muscles of the lower extremity squeezing and pumping regularly, blood cannot efficiently return to the heart. Furthermore, when lower extremity muscles do not contract, there is little demand for oxygen, so the vascular system down regulates and directs the flow of blood away from the area. Thus, a complex series of mechanisms designed to facilitate both arterial and venal blood flow is diminished. Muscle contractions are also known to induce fibrinolysis, which can inhibit the formation of DVT.
[0005] Current approaches to DVT prophylaxis include a wide range of anti-coagulants and sequential compression devices (SCDs). SCDs are typically used as an adjunct therapy to facilitate blood flow to the lower extremities. However, a recent study comparing electrical stimulation to SCDs during total hip and knee arthroplasty to maintain or increase blood flow during the procedure clearly demonstrated that electrical stimulation is superior to SCDs. While cardiac output dropped 20% below baseline, the electrical stimulation group increased 20% (Faghri, IEEE 591 : 62-69; March 1997).
[0006] Neuromuscular stimulation (NMES) is a technique which induces muscles to contract and produce increased blood flow. Involvement of the recipient of NMES in the activation of their muscles is unnecessary because NMES produces muscle activation independent of the recipient's involvement in the physiologic process. This involuntary effect is particularly advantageous for (i) surgical patients who are anesthetized or under a local epidural block; (ii) patients who are bedridden due to disability, age, or disease; or (iii) are paralyzed from spinal cord injury, stroke, or other neurological injuries or diseases. This effect would also be useful for people who are prevented from moving for long periods of time, such as those on long-duration flights or during extended period of sleep.
[0007] Despite the benefits of NMES, traditional electrical stimulation can sometimes be problematic with regard to the application of electrodes. Individual electrodes must be accurately placed over key motor points to elicit a proper muscle contraction. When electrodes are not placed properly, muscle recruitment causes unwanted movement, joint deviation, and heightened
pain and discomfort from the stimulus, or it may not stimulate the muscle at all. Due to the level of skill required in properly placing the electrodes and the number of electrodes typically required for traditional NMES, the broad use of muscle stimulation for DVT prophylaxis in hospitals, for example, is currently impractical. Furthermore, electrical stimulation of muscle in its traditional form often causes discomfort to patients with intact sensation when the level of impulse is high enough to induce mild to moderate muscle contractions. Thus, there is an ongoing need for a system and method for using NMES to increase blood flow to certain regions or areas of the body, particularly the extremities that is relatively easy to implement and that does not cause pain or discomfort to the patient/recipient.
SUMMARY OF THE INVENTION
[0008] The following provides a summary of certain exemplary embodiments of the present invention. This summary is not an extensive overview and is not intended to identify key or critical aspects or elements of the present invention or to delineate its scope.
[0009] In accordance with one aspect of the present invention, a system for electrically stimulating muscles and increasing blood flow in one or more body parts is provided. This system includes at least one electrode adapted to be placed circumferentially (i.e., completely) around a body part such as an arm or leg wherein the at least one electrode is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part; at least one stimulation module in electrical communication with the at least one electrode, wherein the at least one stimulation module is operative to provide electrical impulses to the at least one electrode; and at least one control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
[0010] In accordance with another aspect of the present invention, a system for electrically stimulating muscles and increasing blood flow to a body part is provided. This system includes at least two electrodes adapted to be placed circumferentially around a body part, wherein each of the at least two electrodes is operative to deliver electrical impulses
sufficient to induce muscle contractions in the body part; at least one stimulation module in electrical communication with each of the at least two electrodes, wherein the at least one stimulation module is operative to provide electrical impulses to each of the at least two electrodes; and at least one control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
[0011] In yet another aspect of this invention, a device for electrically stimulating muscles or muscle groups is provided. This device includes at least one electrode adapted to be placed circumferentially (i.e., completely) around a body part such as an arm, leg, or trunk, wherein the at least one electrode is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part.
[0012] Additional features and aspects of the present invention will become apparent to those of ordinary skill in the art upon reading and understanding the following detailed description of the exemplary embodiments. As will be appreciated by the skilled artisan, further embodiments of the invention are possible without departing from the scope and spirit of the invention. Accordingly, the drawings and associated descriptions are to be regarded as illustrative and not restrictive in nature.
BRIEF DESCRIPTION OF THE DRAWINGS
[0013] The accompanying drawings, which are incorporated into and form a part of the specification, schematically illustrate one or more exemplary embodiments of the invention and, together with the general description given above and detailed description given below, serve to explain the principles of the invention, and wherein:
[0014] FIG. 1 depicts an exemplary embodiment of the electrical muscle stimulation system of the present invention wherein multiple electrical stimulation assemblies have been placed on multiple body parts of an individual;
[0015] FIG. 2 illustrates the placement of an exemplary embodiment of the electrical stimulation system of the present invention wherein a single electrical stimulation assembly has been placed on the lower portion of one leg of an individual;
[0016] FIG. 3 is a cross-sectional view of a limb segment depicting the flow of an electrical current into both agonist and antagonist muscle groups from the circumferential electrode of the present invention;
[0017] FIG. 4 is a longitudinal view of a limb segment depicting the flow of an electrical current generated by the circumferential electrodes of the present invention; and
[0018] FIG. 5 is a graph depicting an exemplary order of stimulation for pushing blood proximally using the electrical muscle stimulation system of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[0019] Exemplary embodiments of the present invention are now described with reference to the Figures. Reference numerals are used throughout the detailed description to refer to the various elements and structures. In other instances, well-known structures and devices are shown in block diagram form for purposes of simplifying the description. Although the following detailed description contains many specifics for the purposes of illustration, a person of ordinary skill in the art will appreciate that many variations and alterations to the following details are within the scope of the invention. Accordingly, the following embodiments of the invention are set forth without any loss of generality to, and without imposing limitations upon, the claimed invention.
[0020] The present invention relates to a neuromuscular stimulation system (NMES) for use in treating DVT and other medical and non-medical conditions by inducing singular and or co-contractions of muscle groups to increase blood and oxygen flow in those muscles. Other intended uses and benefits of the present invention include wound healing, muscle strengthening, and stimulation of bone growth. As previously indicated, first and second general embodiments of this invention provide a system for electrically stimulating muscles and increasing blood flow
in one or more body parts such as the trunk or extremities; and a third general embodiment of this invention provides a device in the form of a circumferential electrode for electrically stimulating muscles or muscle groups, wherein the electrode is capable of completely encircling a human body part for increasing blood circulation. The electrode is supplied with electrical impulses to induce muscle contractions and may be shifted proximally or distally on the body part without degradation of muscle contraction while providing for concurrent agonist and antagonist muscle regeneration. With reference now to the Figures, one or more specific embodiments of this invention shall be described in greater detail.
[0021] FIG. 1 depicts an exemplary embodiment of neuromuscular stimulation system
10, wherein multiple electrical stimulation assemblies 20 (or individual electrodes 22 ad 24) have been placed on multiple body parts of an individual. Each assembly 20 typically includes a first circumferential electrode 22 and a second circumferential electrode 24, both of which are in electrical communication with a stimulation module 26, which is connected to each circumferential electrode by at least one wire 28 (see FIG. 2). Stimulation module 26 typically communicates with control module 40 by wireless means, as depicted by reference number 27. Each assembly 20 typically includes a fabric sleeve 30, which acts as a substrate or support for the components thereof. One or more sleeves 30 may be included in a larger garment- like item 32, which may connect sleeves 30 to one another for the purpose a facilitating proper placement of system 10 on a user thereof. FIG. 2 illustrates the placement of an assembly 20 on the lower portion of one leg of an individual.
[0022] FIG. 3 provides a cross-sectional view of a limb segment depicting the flow of an electrical current into both agonist muscle 50 and antagonist muscle 52 from circumferential electrode 22. An electrical field 56 is generated by electrode 22 and passes through skin 54 into the muscles of the limb upon which electrode 22 has been placed. FIG. 4 is a longitudinal view of a limb segment depicting the flow of an electrical current generated by the circumferential electrodes of the present invention. In this Figure, electrodes 22 and 24 have been placed in sequence (i.e., tandem) on the leg of a patient for the purpose of creating electrical field 56. This electrical field is operative to push blood proximally in the leg and increase circulation therein by
inducing a co-contraction (simultaneous contraction) of agonist and antagonist muscles. FIG. 5 provides a graph that depicts an exemplary method of electrical stimulation for pushing blood proximally using an exemplary embodiment of neuromuscular stimulation system 10.
[0023] When system 10 is in use, each muscle group (agonist and antagonist) being treated is typically controlled by one set of circumferential electrodes 22, 24 and one integrated stimulation module 26, which coordinates the electrical impulses between the electrodes, which may be controlled remotely from the electrodes. As will be appreciated by one of ordinary skill in the art, stimulation module 26 is equipped with electronics and battery power used deliver adequate stimulation. Each stimulation module 26 receives a wireless signal 27 from control module 40 for properly coordinating the contraction of muscle groups. Stimulation module 26 may also include electronic means for monitoring contractions of a body part and providing selected electrical impulses to the circumferential electrodes. In an exemplary embodiment, stimulation module 26 has a width of approximately two inches or less and may be extensible in length.
[0024] In an exemplary embodiment, the sequence of muscle contraction is first the dorsiflexors and plantarflexors (triggered simultaneously), then as those muscles begin to relax, the quadriceps and hamstrings (triggered simultaneously) are stimulated (see FIG 5). This produces a natural push of blood cephalad. Through the use of known technology, control module 40 is also capable of monitoring the status of equipment, electrode impedance, compliance and blood flow and then delivering this information to clinicians. Control module 40 may be used to adjust the level of electrical stimulation in accordance with the need for increased or decreased blood flow in or out of the treated limb in a closed-loop feedback manner.
[0025] The circumferential electrodes of the present invention are typically 1-2 inches in width and the area of coverage is significantly higher than the conventional electrodes typically used in NMES. Thus, the current density (CD) of the circumferential electrodes is significantly lower, even at high intensity outputs, meaning they are more comfortable than conventional electrodes. For example a conventional electrode would have an area of 2 x 4 inches equaling 8
square inches; whereas a circumferential electrode (around a typical thigh) would have an area 1 x 25 inches equaling 25 square inches. With a conventional electrode, a current density of 10OmA equals 100 mA per 8 square inches or 12.5 mA per square inch; whereas with a circumferential electrode, a current density of 100mA equals 100 mA per 25 square inches or 4 mA per square inch. In an exemplary embodiment, the electrical impulse parameters for each circumferential electrode include an amplitude of about 0.1-150 mA; a pulse width of about 0.1- 400 microseconds; a frequency of 25-50 Hz; and a duty cycle of about 5-10 seconds ON, and about 10-60 seconds OFF.
[0026] In certain embodiments of this invention, circumferential electrodes 22, 24 utilize either an adhesive or non-adhesive biogel to interface with the patient's skin. This biogel may include hydrogel polymers, polymerized polyethylene glycol diacrylate, polylactic acid, polyglycolic acid, polymerized polyethylene glycol dimethylacrylate and mixtures thereof. The circumferential electrodes of the present invention are extensible in length (including the biogel) to accommodate expansion in girth as muscle contracts so as to not constrict the limbs and to maintain electrode-to-skin contact; and are flexible for accommodating the contours of limbs which may vary widely due to variations in underlying muscle and bone. Neuromuscular stimulation system 10 and the various components thereof may be provided as a portable kit that includes instructions for proper placement of the electrodes and proper use of the system.
[0027] A primary advantage of the present invention is that circumferential electrodes 22,
24 transmit electrical current through the patient's skin and body in a highly efficient manner. The electrical current generated by these circumferential electrodes travels in a perpendicular fashion with respect to the planar surface of the electrode and then along a parallel pathway, in the long direction of the limb segment (see FIGS 3-4). These aspects of the disclosed circumferential electrodes results in much less discomfort to the patient. The reduced level of discomfort is also due to lower current densities emitted by the circumferential electrodes as compared to more traditional electrodes. Furthermore, the circumferential electrodes of the present invention do not have to be placed accurately to effectively excite muscle tissue. These electrodes may be shifted proximally or distally, while still inducing muscle contractions without
compromising the quality of stimulation or level of comfort. Finally, as previously discussed, the disclosed circumferential electrodes reduce the number of required electrodes and stimulation channels by one-half, making a NMES system utilizing these electrodes far easier to operate than known systems.
[0028] While the present invention has been illustrated by the description of exemplary embodiments thereof, and while the embodiments have been described in certain detail, it is not the intention of the Applicant to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. Therefore, the invention in its broader aspects is not limited to any of the specific details, representative devices and methods, and/or illustrative examples shown and described. Accordingly, departures may be made from such details without departing from the spirit or scope of the Applicant's general inventive concept.
Claims
(1) A system for stimulating muscles and increasing blood flow, comprising:
(a) at least one electrode adapted to be placed circumferentially around a body part, wherein the at least one electrode is operative to deliver electrical impulses
sufficient to induce muscle contractions in the body part;
(b) at least one stimulation module in electrical communication with the at least one electrode, wherein the at least one stimulation module is operative to provide electrical impulses to the at least one electrode; and
(c) a control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
(2) The system of claim 1 , further comprising a biogel for providing an interface between the electrode and the body part, and wherein the biogel is adhesive or non-adhesive.
(3) The system of claim 2, wherein the biogel is a hydrogel polymer, polymerized
polyethylene glycol diacrylate, polylactic acid, polyglycolic acid, polymerized polyethylene glycol dimethylacrylate, or combinations thereof.
(4) The system of claim 1, wherein the electrode is about 1-2 inches in width.
(5) The system of claim 1, wherein the electrode is extensible in length.
(6) The system of claim 1 , wherein each electrical impulse has an amplitude of from about 0.01 to 15OmA, a pulse width of from about 0.01 to 400 microseconds, a frequency of from about 25 to 50 Hz, and a duty cycle of from about of from 5 to 10 seconds on and from 10 to 60 seconds off.
(7) The system of claim 1 , wherein the control module is further operative to monitor the muscle contractions and adjust the electrical impulses to increase or decrease blood flow in the body part.
(8) A system for stimulating muscles and increasing blood flow, comprising:
(a) at least two electrodes adapted to be placed circumferentially around a body part, wherein each of the at least two electrodes is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part;
(b) at least one stimulation module in electrical communication with each of the at least two electrodes, wherein the at least one stimulation module is operative to provide electrical impulses to each of the at least two electrodes; and
(c) at least one control module in electrical communication with the at least one stimulation module, wherein the at least one control module is operative to control the characteristics of the electrical impulses.
(9) The system of claim 8, further comprising a biogel for providing an interface between the electrodes and the body part, and wherein the biogel is adhesive or non-adhesive.
(10) The system of claim 9, wherein the biogel is a hydrogel polymer, polymerized
polyethylene glycol diacrylate, polylactic acid, polyglycolic acid, polymerized polyethylene glycol dimethylacrylate, or combinations thereof.
(11) The system of claim 8, wherein the electrodes are about 1-2 inches in width and are
extensible in length.
(12) The system of claim 8, wherein the electrodes are operative to treat DVT, affect wound healing, increase muscle strength, or stimulate bone growth.
(13) The system of claim 8, wherein each electrical impulse has an amplitude of from about 0.01 to 15OmA, a pulse width of from about 0.01 to 400 microseconds, a frequency of
from about 25 to 50 Hz, and a duty cycle of from about of from 5 to 10 seconds on and from 10 to 60 seconds off.
(14) The system of claim 8, wherein the control module is further operative to monitor the muscle contractions and adjust the electrical impulses to increase or decrease blood flow in the body part.
(15) A device for electrically stimulating muscles, comprising: at least one electrode adapted to be placed circumferentially around a body part, wherein the at least one electrode is operative to deliver electrical impulses sufficient to induce muscle contractions in the body part.
(16) The device of claim 15, wherein the at least one electrode is adapted to communicate with at least one stimulation module, and wherein the at least one stimulation module is operative to provide electrical impulses to the at least one electrode.
(17) The device of claim 16, wherein each electrical impulse has an amplitude of from about 0.01 to 15OmA, a pulse width of from about 0.01 to 400 microseconds, a frequency of from about 25 to 50 Hz, and a duty cycle of from about of from 5 to 10 seconds on and from 10 to 60 seconds off.
(18) The device of claim 15, wherein the stimulation module is adapted to communicate with at least one control module, and wherein the at least one control module is operative to control the characteristics of the electrical impulses.
(19) The device of claim 15, wherein the electrode is about 1-2 inches in width and is
extensible in length.
(20) The device of claim 15, wherein the electrode is operative to treat DVT, affect wound healing, increase muscle strength, or stimulate bone growth.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20090847449 EP2453974A4 (en) | 2009-07-15 | 2009-09-22 | System for using electrical muscle stimulation to increase blood flow in body parts |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22570309P | 2009-07-15 | 2009-07-15 | |
US61/225,703 | 2009-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011008222A1 true WO2011008222A1 (en) | 2011-01-20 |
Family
ID=43449638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/057838 WO2011008222A1 (en) | 2009-07-15 | 2009-09-22 | System for using electrical muscle stimulation to increase blood flow in body parts |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2453974A4 (en) |
WO (1) | WO2011008222A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016151159A1 (en) * | 2015-03-26 | 2016-09-29 | María Olga Salcedo Lailla | Blood flow stimulator for the lower limbs |
EP3010579A4 (en) * | 2013-06-21 | 2017-02-22 | Bodyflow International Pty Ltd Acn 114 356 231 | Treating skin ulcers |
CN108785850A (en) * | 2012-06-26 | 2018-11-13 | 斯凯医疗技术有限公司 | Equipment for enhancing microcirculation |
WO2021178040A1 (en) * | 2020-03-03 | 2021-09-10 | Garwood Medical Devices, Llc | Circumferentially wrappable electrode for use with metal surgical implants |
EP4147747A1 (en) * | 2016-06-30 | 2023-03-15 | Novocure GmbH | Arrays for longitudinal delivery of ttfields to a body |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674262A (en) * | 1996-01-26 | 1997-10-07 | Kinetic Concepts, Inc. | Pneumatic compression and functional electric stimulation device and method using the same |
US20030114892A1 (en) * | 2001-12-18 | 2003-06-19 | Ness Neuromuscular Electrical Stimulation Systems Ltd. | Surface neuroprosthetic device having an internal cushion interface system |
US20040254624A1 (en) * | 2003-06-06 | 2004-12-16 | Prizm Medical, Inc. | Electrical stimulator and garment electrode connection system |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4727878A (en) * | 1985-09-26 | 1988-03-01 | The University Of Michigan | Functional electrical stimulation for pressure sore inhibition |
US6002965A (en) * | 1998-06-10 | 1999-12-14 | Katz; Amiram | Self applied device and method for prevention of deep vein thrombosis |
US6463327B1 (en) * | 1998-06-11 | 2002-10-08 | Cprx Llc | Stimulatory device and methods to electrically stimulate the phrenic nerve |
US5871534A (en) * | 1998-07-08 | 1999-02-16 | Messick; Genevieve M. | Apparatus for treating pelvic floor dysfunctions using transcutaneous electrical stimulation of the muscles |
ATE348646T1 (en) * | 2000-02-17 | 2007-01-15 | Neurodan As | IMPLANTABLE SYSTEM FOR NEURAL MEASUREMENT AND NERVE STIMULATION |
GB2370507B (en) * | 2000-12-23 | 2003-07-30 | Nuron Ltd | Apparatus for the diagnosis and therapy of neuro-muscular and other tissue disorders |
JP2005052223A (en) * | 2003-08-06 | 2005-03-03 | Gifu Univ | Peripheral blood circulation improving device |
CA2537177C (en) * | 2003-09-03 | 2010-05-18 | Fides Finanz-Invest Gmbh & Co. Kg | Device for muscle stimulation |
GB0425632D0 (en) * | 2004-11-22 | 2004-12-22 | Bioaccelerate Ltd | Device |
US7991476B2 (en) * | 2006-05-22 | 2011-08-02 | Empire Bio-Medical Devices, Inc. | Method and device for enhanced blood flow |
US20080097530A1 (en) * | 2006-10-23 | 2008-04-24 | Muccio Philip | System for tissue stimulation and regeneration |
-
2009
- 2009-09-22 WO PCT/US2009/057838 patent/WO2011008222A1/en active Application Filing
- 2009-09-22 EP EP20090847449 patent/EP2453974A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674262A (en) * | 1996-01-26 | 1997-10-07 | Kinetic Concepts, Inc. | Pneumatic compression and functional electric stimulation device and method using the same |
US20030114892A1 (en) * | 2001-12-18 | 2003-06-19 | Ness Neuromuscular Electrical Stimulation Systems Ltd. | Surface neuroprosthetic device having an internal cushion interface system |
US20040254624A1 (en) * | 2003-06-06 | 2004-12-16 | Prizm Medical, Inc. | Electrical stimulator and garment electrode connection system |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108785850A (en) * | 2012-06-26 | 2018-11-13 | 斯凯医疗技术有限公司 | Equipment for enhancing microcirculation |
EP3010579A4 (en) * | 2013-06-21 | 2017-02-22 | Bodyflow International Pty Ltd Acn 114 356 231 | Treating skin ulcers |
WO2016151159A1 (en) * | 2015-03-26 | 2016-09-29 | María Olga Salcedo Lailla | Blood flow stimulator for the lower limbs |
EP4147747A1 (en) * | 2016-06-30 | 2023-03-15 | Novocure GmbH | Arrays for longitudinal delivery of ttfields to a body |
US11964146B2 (en) | 2016-06-30 | 2024-04-23 | Novocure Gmbh | Arrays for longitudinal delivery of TTFields to a body |
WO2021178040A1 (en) * | 2020-03-03 | 2021-09-10 | Garwood Medical Devices, Llc | Circumferentially wrappable electrode for use with metal surgical implants |
Also Published As
Publication number | Publication date |
---|---|
EP2453974A1 (en) | 2012-05-23 |
EP2453974A4 (en) | 2013-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110071595A1 (en) | System for using electrical muscle stimulation to increase blood flow in body parts | |
AU2019333201B2 (en) | System, method, and apparatus for applying transcutaneous electrical stimulation | |
Faghri et al. | Electrical stimulation-induced contraction to reduce blood stasis during arthroplasty | |
US9031659B2 (en) | Method and apparatus for laryngeal elevator musculature rehabilitation | |
US9925374B2 (en) | Treatment of indications using electrical stimulation | |
US20150032184A1 (en) | Neuromuscular stimulation system | |
US20070049814A1 (en) | System and device for neuromuscular stimulation | |
US20130204169A1 (en) | Pain Management Device and System | |
JPH08511445A (en) | Nerve stimulator and link support | |
JP2010505471A (en) | Method and apparatus for magnetic induction therapy | |
WO2011008222A1 (en) | System for using electrical muscle stimulation to increase blood flow in body parts | |
JP2012217565A (en) | Urination disorder treatment device | |
US20210016087A1 (en) | Occlusion therapy and pelvic stimulation system | |
Von Wild et al. | Computer added locomotion by implanted electrical stimulation in paraplegic patients (SUAW) | |
US7747328B2 (en) | Method and apparatus for treating a wound | |
US20220395686A1 (en) | Neural Block by Super-Threshold Low Frequency Electrical Stimulation | |
JP2001238967A (en) | Skin state feedback type bedsore preventive and therapeutic system | |
Graupe et al. | Electromyographic control of functional electrical stimulation in selected patients | |
US10888698B2 (en) | Apparatus and method for prevention and mitigation of deep vein thrombosis | |
JP2005521488A (en) | Muscle stimulation method in limbs with cast cast | |
US9968773B1 (en) | Method and system for rehabilitation of scar tissue | |
Gorman et al. | Functional electrical stimulation in neurorehabilitation | |
KR20190138826A (en) | How to form arteriovenous connections | |
CN110384861B (en) | Injectable piezoelectric transducer, injection device, nerve stimulation system and method | |
RU2684178C1 (en) | Method of rehabilitation after total knee endoprosthesis replacementin patients with sarcopenia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09847449 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009847449 Country of ref document: EP |